Abstract
The peroxisome proliferator activated receptor gamma coactivator‐1alpha (PGC‐1α) is a transcriptional activator of many metabolic genes, especially those used in the metabolism of fatty acids. Within the failing heart, a metabolic shift occurs from utilizing mainly fatty acids to relying more on glycolysis. Concurrent with this shift is a reduction in the expression of PGC‐1α and an increase in the glucose‐derived, metabolic post‐translational modification O‐GlcNAc. We hypothesized that O‐GlcNAc signaling would play a role in the control of PGC‐1α during this metabolic change. We subjected wild‐type mice to coronary ligation (HF) or sham. After five days both PGC‐1α and PGC‐1 α levels were significantly reduced (p<0.05) and O‐GlcNAc levels significantly elevated (p<0.05). Using the MerCreMer transgene system coupled with a loxP‐flanked OGT mouse, a cardiomyocyte specific OGT 'KO' was made. After tamoxifen induction, cardiac OGT and O‐GlcNAc levels were significantly reduced (p<0.05) in the transgenic (Tg) group. NTg and Tg mice underwent HF or sham surgery and tissues were harvested after 5 days. Following HF, Tg mice exhibited a greater reduction in PGC levels (figure A, p>0.05) than their NTg counterparts. We conclude that ablation of OGT exacerbates the suppression of PGC‐1α in the failing heart.Funded by the NIH and American Heart Association.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.